Balyasny Asset Management LLC Intra Cellular Therapies, Inc. Transaction History

Balyasny Asset Management LLC

$58 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$64.76 - $79.84 $253,859 - $312,972	-3,920 Reduced 0.95%	406,714 $27.9 Million
Q1 2024 May 13, 2024	BUY	$64.37 - $75.65 $6.48 Million - $7.61 Million	100,641 Added 32.47%	410,634 $28.4 Million
Q4 2023 Feb 14, 2024	BUY	$46.37 - $73.65 $14.4 Million - $22.8 Million	309,993 New	309,993 $22.2 Million
Q2 2023 Aug 14, 2023	BUY	$54.67 - $66.44 $6.74 Million - $8.19 Million	123,282 Added 1683.03%	130,607 $8.27 Million
Q1 2023 May 15, 2023	BUY	$43.8 - $56.99 $291,576 - $379,382	6,657 Added 996.56%	7,325 $396,000
Q4 2022 Feb 14, 2023	SELL	$44.07 - $54.45 $204,484 - $252,648	-4,640 Reduced 87.42%	668 $35,000
Q3 2022 Nov 14, 2022	BUY	$42.7 - $59.99 $226,651 - $318,426	5,308 New	5,308 $247,000
Q2 2022 Aug 15, 2022	SELL	$43.0 - $65.64 $1.37 Million - $2.1 Million	-31,967 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$38.74 - $62.09 $1.24 Million - $1.98 Million	31,967 New	31,967 $1.96 Million
Q4 2018 Feb 14, 2019	SELL	$10.36 - $20.96 $5.27 Million - $10.7 Million	-508,750 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$17.77 - $22.9 $903,764 - $1.16 Million	50,859 Added 11.11%	508,750 $11 Million
Q2 2018 Aug 14, 2018	BUY	$17.33 - $23.4 $966,407 - $1.3 Million	55,765 Added 13.87%	457,891 $8.09 Million
Q1 2018 May 15, 2018	BUY	$15.16 - $25.49 $4.43 Million - $7.44 Million	291,973 Added 265.06%	402,126 $8.47 Million
Q4 2017 Feb 14, 2018	SELL	$14.27 - $16.79 $416,684 - $490,268	-29,200 Reduced 20.95%	110,153 $1.6 Million
Q3 2017 Nov 14, 2017	BUY	$10.77 - $22.1 $1.5 Million - $3.08 Million	139,353	139,353 $2.2 Million

Others Institutions Holding ITCI

# of Institutions

378

Shares Held

84.7M

Call Options Held

319K

Put Options Held

143K

Vanguard Group Inc Valley Forge, PA

9.63M
Shares

$800 Million
0.01% of portfolio
Black Rock Inc. New York, NY

6.32M
Shares

$525 Million
0.01% of portfolio
Jpmorgan Chase & CO New York, NY

5.29M
Shares

$439 Million
0.03% of portfolio
Wasatch Advisors Inc Salt Lake City, UT

3.85M
Shares

$320 Million
1.4% of portfolio
Avoro Capital Advisors LLC New York, NY

3.05M
Shares

$253 Million
3.36% of portfolio

View Full List

About Intra-Cellular Therapies, Inc.

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $7.85B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

More about ITCI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Account